TRIPLE AGONIST (RESEARCH)
Retatrutide
Retatrutide is an investigational triple agonist of the GLP-1, GIP, and glucagon receptors under study for significant weight reduction and metabolic improvement in early clinical trials.
VIAL SIZE
10 mg lyophilized
PURITY
>99% (HPLC, placeholder)
Buy more, get free vials.
Buy 1 get 1 free · Buy 4 get 2 free · Buy 6 get 3 free.
Add 3 more — unlock 2 free vials.
+1 FREE VIAL APPLIED
$69.69
PER VIAL
Research dosing
Research protocols typically start low (e.g. 2 mg weekly) and titrate. Placeholder — verify with current literature.
Reconstitution
Reconstitute with 2 mL bacteriostatic water for a 5 mg/mL concentration.
Storage
Refrigerate at 2–8°C after reconstitution. Store lyophilized vial at –20°C.
Research context
Studied in Phase 2 trials for obesity, type 2 diabetes, and MASLD with significant weight-reduction signals.
For laboratory research use only. Not for human consumption. Information shown is for research reference; dosing and storage details on this page are placeholders pending finalized internal documentation.